Our diverse team members bring with them extensive work experience and expertise in their respective fields. We are dedicated to innovating non-invasive clinical applications for early detection of cancer. We are committed to rigorous testing, data-driven processing, accurate unbiased reporting, and to engineer highly accurate and reliable diagnostic tools. Our goal is to make a significant impact on improving the survivability of cancer.
CEO, CFO, Cofounder
Tom drives business direction, approves company strategies, and oversees financial and risk planning activities.
COO, CSO, Cofounder, SAB Member
Cherylle directs operational strategies and scientific direction, reviews results, and provides risk assessments.
CIO, Cofounder, SAB Member
Christopher directs and audits statistical approaches for algorithm development and oversees information technology operations.
Lung Cancer Proteomics, LLC
105 Washington Street
Michigan City, IN 46360
Bay Area Laboratory
780 Montague Expressway
Building 7, Suite 703
San Jose, CA 95131